Systematic analysis of protein targets associated with adverse events of drugs from clinical trials and post-marketing reports
Ines A. Smit, Avid M. Afzal, Chad H. G. Allen, et al.
AND
Toward in vivo-relevant hERG safety assessment and mitigation strategies based on relationships between non-equilibrium blocker binding, three-dimensional channel-blocker interactions, dynamic occupancy, dynamic exposure, and cellular arrhythmia
Hongbin Wan, Gianluca Selvaggio, Robert A. Pearlstein
